Terms: = Prostate cancer AND CTLA4, ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4, GSE, IDDM12 AND Clinical Outcome
7 results:
1. Prevalence of tumour-infiltrating CD103
Zhou Q; Ou Y; Dai X; Chen X; Wu S; Chen W; Hu M; Yang C; Zhang L; Jiang H
Br J Cancer; 2023 Apr; 128(8):1466-1477. PubMed ID: 36759726
[TBL] [Abstract] [Full Text] [Related]
2. Immune Checkpoints, Inhibitors and Radionuclides in prostate cancer: Promising Combinatorial Therapy Approach.
Kgatle MM; Boshomane TMG; Lawal IO; Mokoala KMG; Mokgoro NP; Lourens N; Kairemo K; Zeevaart JR; Vorster M; Sathekge MM
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921181
[TBL] [Abstract] [Full Text] [Related]
3. Hypoxia and angiogenic biomarkers in prostate cancer after external beam radiotherapy (EBRT) alone or combined with high-dose-rate brachytherapy boost (HDR-BTb).
Bhattacharya IS; Taghavi Azar Sharabiani M; Alonzi R; Hoskin PJ
Radiother Oncol; 2019 Aug; 137():38-44. PubMed ID: 31059955
[TBL] [Abstract] [Full Text] [Related]
4. Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in prostate cancer Patients Treated with Ipilimumab.
Kwek SS; Lewis J; Zhang L; Weinberg V; Greaney SK; Harzstark AL; Lin AM; Ryan CJ; Small EJ; Fong L
Cancer Immunol Res; 2015 Sep; 3(9):1008-16. PubMed ID: 25968455
[TBL] [Abstract] [Full Text] [Related]
5. Improved survival with T cell clonotype stability after anti-ctla-4 treatment in cancer patients.
Cha E; Klinger M; Hou Y; Cummings C; Ribas A; Faham M; Fong L
Sci Transl Med; 2014 May; 6(238):238ra70. PubMed ID: 24871131
[TBL] [Abstract] [Full Text] [Related]
6. Genome-wide association study identifies new prostate cancer susceptibility loci.
Schumacher FR; Berndt SI; Siddiq A; Jacobs KB; Wang Z; Lindstrom S; Stevens VL; Chen C; Mondul AM; Travis RC; Stram DO; Eeles RA; Easton DF; Giles G; Hopper JL; Neal DE; Hamdy FC; Donovan JL; Muir K; Al Olama AA; Kote-Jarai Z; Guy M; Severi G; Grönberg H; Isaacs WB; Karlsson R; Wiklund F; Xu J; Allen NE; Andriole GL; Barricarte A; Boeing H; Bueno-de-Mesquita HB; Crawford ED; Diver WR; Gonzalez CA; Gaziano JM; Giovannucci EL; Johansson M; Le Marchand L; Ma J; Sieri S; Stattin P; Stampfer MJ; Tjonneland A; Vineis P; Virtamo J; Vogel U; Weinstein SJ; Yeager M; Thun MJ; Kolonel LN; Henderson BE; Albanes D; Hayes RB; Feigelson HS; Riboli E; Hunter DJ; Chanock SJ; Haiman CA; Kraft P
Hum Mol Genet; 2011 Oct; 20(19):3867-75. PubMed ID: 21743057
[TBL] [Abstract] [Full Text] [Related]
7. E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage, and clinical outcome.
Ross JS; Figge HL; Bui HX; del Rosario AD; Fisher HA; Nazeer T; Jennings TA; Ingle R; Kim DN
Mod Pathol; 1994 Oct; 7(8):835-41. PubMed ID: 7530850
[TBL] [Abstract] [Full Text] [Related]
